NCT05293197View on ClinicalTrials.gov

Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 6, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
Malignant Brain TumorMalignant GliomaEmbryonal Tumor
Interventions
DEVICE

SonoCloud® (9 transducers)

SonoCloud®, sonication: dose escalation 6 cycles of sonication

Trial Locations (3)

75005

RECRUITING

Institut Curie, Paris

75015

RECRUITING

Service de neurochirugie Pédiatrique - Hôpital Necker- Enfants Malades, Paris

94800

RECRUITING

Institut Gustave Roussy, Villejuif

Sponsors

Collaborators (1)

CarThera
All Listed Sponsors
collaborator

CarThera

INDUSTRY

collaborator

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

collaborator

Institut Curie

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05293197 - Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients | Biotech Hunter | Biotech Hunter